Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
311.00    0.00 (0.00%)
Bid:
310.00
Ask:
312.00
Spread: 2.00 (0.645%)
Market Cap: £39.46m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Total Voting Rights

1 Mar 2017 14:02

RNS Number : 2521Y
BrainJuicer Group PLC
01 March 2017
 

 

 

 

Press Release

1 March 2017

BrainJuicer Group PLC (AIM: BJU)

("BrainJuicer" or the "Company")

 

Total Voting Rights

 

As at 28 February 2017, the total number of Ordinary Shares with voting rights was 12,264,784, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, BrainJuicer Group PLC under the FCA's Disclosure and Transparency Rules. The Company holds 961,989 Ordinary Shares as treasury shares.

 

 

 

For further information, please contact:

BrainJuicer Group PLC

 +44 (0)20 7043 1000

John Kearon, Chief Executive Officer

 

James Geddes, Chief Financial Officer

 

Canaccord Genuity Limited (Nomad & Broker)

+44 (0)20 7523 8000

Simon Bridges / Emma Gabriel

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRBSGDXBGGBGRB
Date   Source Headline
5th Jun 20077:03 amRNSProgress - Predictive Markets
25th May 200712:45 pmRNSResult of AGM
30th Apr 20077:01 amRNSTotal Voting Rights
25th Apr 20075:41 pmRNSIssue of Equity
12th Apr 20077:01 amRNSPreliminary Results
5th Apr 20077:01 amRNSNotice of Results
19th Jan 20075:10 pmRNSDirector/PDMR Shareholding
15th Dec 200611:13 amRNSTotal Voting Rights
5th Dec 20068:00 amRNSFirst Day of Dealings on AiM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.